Legal Representation
Attorney
Enshan Hong
USPTO Deadlines
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 25, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Apr 25, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Apr 25, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Oct 11, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 11, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 11, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 4, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 1, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 1, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 1, 2022 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Sep 1, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 5, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 3, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Medical services; Medical consulting services in the field of disease infection control; Providing medical care services and consultation related thereto; Pharmaceutical and medical consultancy; Providing healthcare information and advisory services in the healthcare field; Medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; Medical services, namely, providing therapies for treating proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases and neurodegenerative disease; Medical services, namely, providing therapeutic and prophylactic treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases, and neurodegenerative disease; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes
First Use Anywhere:
May 10, 2021
First Use in Commerce:
May 10, 2021
Additional Information
Design Mark
The mark consists of stylized wording "REVIR".
Classification
International Classes
044